Frank L. Porfido
Keine laufenden Positionen mehr
Karriereverlauf von Frank L. Porfido
Ehemalige bekannte Positionen von Frank L. Porfido
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TYME TECHNOLOGIES, INC. | Finanzdirektor/CFO | 13.05.2021 | 16.09.2022 |
| UroGen Pharma, Inc. | Corporate Officer/Principal | 01.06.2019 | 01.05.2021 |
Ausbildung von Frank L. Porfido
| Pace University | Undergraduate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
| UroGen Pharma, Inc. | Health Technology |
- Börse
- Insiders
- Frank L. Porfido
- Erfahrung
